Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease

The potential therapeutic benefit of intravenous immunoglobulins (IVIGs) for acute attacks of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is unknown. The objective was to describe the outcomes of IVIG treatment for acute MOGAD attacks. A retrospective observational study involving s...

Full description

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis Vol. 29; no. 9; p. 1080
Main Authors:	Lotan, Itay, Chen, John J, Hacohen, Yael, Abdel-Mannan, Omar, Mariotto, Sara, Huda, Saif, Gibbons, Emily, Wilf-Yarkoni, Adi, Hellmann, Mark A, Stiebel-Kalish, Hadas, Pittock, Sean J, Flanagan, Eoin P, Molazadeh, Negar, Anderson, Monique, Salky, Rebecca, Romanow, Gabriela, Schindler, Patrick, Duchow, Ankelien Solveig, Paul, Friedemann, Levy, Michael
Format:	Journal Article
Language:	English
Published:	England 01.08.2023
Subjects:	Autoantibodies Encephalomyelitis, Acute Disseminated - drug therapy Female Humans Immunoglobulins, Intravenous - therapeutic use Male Myelin-Oligodendrocyte Glycoprotein Myelitis, Transverse Neuromyelitis Optica Retrospective Studies effectiveness IVIG MOGAD outcomes safety acute treatment
ISSN:	1477-0970, 1477-0970
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!